论文部分内容阅读
陪他定是治疗美尼尔氏病安全有效的一种组织胺类药物。其原理被认为是改善了内耳微循环。作者为了明确该药在治疗其它外周性前庭性眩晕疾病中的疗效,进行了双盲交叉对比试验。按照Kane&Strong(1957)所订标准,选择27例外周性前庭性眩晕病人。病史在2月以上,年龄均在70岁以下。患有中耳、鼻窦感染,眼病,中枢性或精神病,颈椎病变,内分泌紊乱,支气管哮喘,消化道溃疡者均被除外。病人分成二组。6周服用陪他定(12mg,每日三次),6周服用安慰剂,服药顺序两组相反。试验前对病人
Accompany him set is a histamine drug for the treatment of Meniere’s disease is safe and effective. The principle is considered to improve the inner ear microcirculation. In order to clarify the efficacy of the drug in the treatment of other peripheral vestibular vertigo diseases, a double-blind crossover comparison test was performed. According to the criteria set by Kane & Strong (1957), 27 patients with peripheral vestibular vertigo were selected. A history of more than in February, both under 70 years of age. Suffering from the middle ear, sinus infection, eye disease, central or mental illness, cervical lesions, endocrine disorders, bronchial asthma, peptic ulcer were excluded. The patient is divided into two groups. 6 weeks to take with him set (12mg, three times daily), 6 weeks taking placebo, taking the opposite order of the two groups. Before the test on the patient